Faye Hant to Respiratory Function Tests
This is a "connection" page, showing publications Faye Hant has written about Respiratory Function Tests.
Connection Strength
0.299
-
Pulmonary manifestations of scleroderma and mixed connective tissue disease. Clin Chest Med. 2010 Sep; 31(3):433-49.
Score: 0.089
-
Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma. J Rheumatol. 2009 Apr; 36(4):773-80.
Score: 0.081
-
Performance Characteristics of Pulmonary Function Tests for the Detection of Interstitial Lung Disease in Adults With Early Diffuse Cutaneous Systemic Sclerosis. Arthritis Rheumatol. 2020 11; 72(11):1892-1896.
Score: 0.045
-
Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18. Arthritis Rheumatol. 2019 12; 71(12):2059-2067.
Score: 0.042
-
Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registry. Clin Rheumatol. 2020 Jan; 39(1):93-102.
Score: 0.042